Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy

被引:20
|
作者
Diedrich, Chantal M. [1 ]
Kastelein, Arnoud W. [1 ]
Verri, Filippo M. [1 ]
Weber, Maaike A. [1 ]
Ince, Can [2 ,3 ]
Roovers, Jan-Paul W. R. [1 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam UMC, Dept Translat Physiol, Amsterdam, Netherlands
[3] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands
关键词
estrogen; imaging; microcirculation; vulvovaginal atrophy;
D O I
10.1002/nau.23977
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims This study aims to assess vaginal wall angioarchitecture and function in women with vulvovaginal atrophy (VVA) and determine the effect of topical estrogen on the vaginal microcirculation. Materials and Methods In this prospective observational study, incident dark field imaging was used to assess the vaginal microcirculation. In patients with VVA, measurements were performed before and after treatment with topical estrogen and compared to measurements performed in women without VVA. Vaginal angioarchitecture was studied by assessing microcirculatory architecture and capillary tortuosity scores at four regions of the vaginal wall. In addition, the capillary density and microvascular flow index (MFI) were obtained. Results Seventeen women were included in this study. Of these, eight women were diagnosed with VVA and nine women were considered healthy controls. Significant differences were observed between groups with regard to microcirculatory architecture scores. The architecture of the microvasculature in women with VVA was characterized by the appearance of a vascular network without capillary loops, whereas an array of capillary loops was predominantly seen in women without VVA. After estrogen treatment, no difference in architecture scores between patients and healthy controls was observed. Capillary tortuosity, capillary density, and MFI were similar in both groups before and after estrogen treatment. Conclusions The architecture of vaginal microvasculature is altered in patients with VVA. In case of similar vascular architecture, capillary tortuosity and density seem to be comparable. Treatment with topical estrogen results in restoration of the angioarchitecture.
引用
收藏
页码:1298 / 1304
页数:7
相关论文
共 50 条
  • [1] VAGINAL ESTROGEN THERAPY FOR VULVOVAGINAL ATROPHY IN WOMEN WITH A PERSONAL HISTORY OF BREAST CANCER - A CLAIMS DATABASE ANALYSIS
    Dumas, K.
    Singh, S.
    Kohn, J.
    Kohn, T.
    Clifton, M.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (08): : S4 - S4
  • [2] Effects of Vulvovaginal Laser Therapy on Postmenopausal Vaginal Atrophy: A Prospective Study
    Singh, Priyanka
    Chong, Christopher Yew Luen
    Han, How Chuan
    JOURNAL OF GYNECOLOGIC SURGERY, 2019, 35 (02) : 99 - 104
  • [3] Effects of vulvovaginal laser therapy on postmenopausal vaginal atrophy: A prospective study
    Singh, P.
    Han, H. C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2018, 29 : S159 - S160
  • [4] Effects of vaginal DHEA on stress urinary incontinence in postmenopausal women with vulvovaginal atrophy
    Misasi, Giulia
    Russo, Eleonora
    Guevara, Maria Magdalena Montt
    Tomatis, Veronica
    Fidecicchi, Tiziana
    Luisi, Stefano
    Giannini, Andrea
    Mannella, Paolo
    Caretto, Marta
    Pomara, Giorgio
    Simoncini, Tommaso
    MATURITAS, 2025, 196
  • [5] Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial
    Mária Faltinová
    Leena Vehmanen
    Heli Lyytinen
    Hanna Savolainen-Peltonen
    Anni Virtanen
    Mikko Haanpää
    Esa Hämäläinen
    Aila Tiitinen
    Johanna Mattson
    Breast Cancer Research and Treatment, 2025, 210 (2) : 295 - 305
  • [6] Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial
    de Moraes, Anna Valeria Gueldini
    Costa-Paiva, Lucia
    da Costa Machado, Helymar
    Maciel, Tayna Figueiredo
    Mariano, Fernanda Viviane
    Pedro, Adriana Orcesi
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (04): : 288 - 302
  • [7] Effect of ospemifene on vaginal microbiome in postmenopausal women with vulvovaginal atrophy
    Alvisi, Stefania
    Ceccarani, Camilla
    Foschi, Claudio
    Baldassarre, Maurizio
    Lami, Alessandra
    Severgnini, Marco
    Camboni, Tania
    Consolandi, Clarissa
    Seracchioli, Renato
    Meriggiola, Maria Cristina
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (04): : 361 - 369
  • [8] Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview
    Al-Baghdadi, O.
    Ewies, A. A. A.
    CLIMACTERIC, 2009, 12 (02) : 91 - 105
  • [9] EFFECT OF VAGINAL ESTROGEN DELIVERY ON THE VAGINAL MUSCULARIS IN A RODENT MODEL OF VULVOVAGINAL ATROPHY WITH MENOPAUSE.
    Pepe, Nicole
    Doda, Lauren
    Stewart, Sarah
    Mattox, Millie
    Basha, Maureen
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1093 - E1094
  • [10] Molecular Effects of Topical Estrogen on Vaginal Granulation Tissue in Postpartum Women
    Bochenska, Katarzyna
    Kujawa, Stacy
    Zhao, Hong
    Kenton, Kimberly
    Bulun, Serdar E.
    Lewicky-Gaupp, Christina
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (08): : 521 - 526